Forward Osmosis

A membrane technology that separates two solutions based on the difference in their osmotic potential.

LUX TAKE:

Many early-stage companies in FO initially targeted seawater desalination to produce drinking water or process water, but the two-step FO process has yet to successfully compete with the incumbent technology in the space. However, new developments, both in research and from startups, make FO "a force to reckon with" for separations of high value and industrial wastewater. The technology's low ...

Data last updated on January 30, 2020

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent forward osmosis developments.

News Commentaries

Lawrence Berkeley National Laboratory develops ionic liquid separation process for forward osmosis and brine concentration (October 17, 2019)

Modern Water plans to sell its water quality monitoring division to rapidly commercialize membrane offerings (October 3, 2019)

New Lux Content

Separation Technology 2019 Year in Review (January 30, 2020)

Aquafortus (June 13, 2019)

New Patents

Computing...

New Investment Rounds

Computing...

Related companies	Porifera, Oasys Water, Agua Via, Aquaporin, Applied Biomimetic, Forward Water Technologies, Hydroxsys NZ, Trevi Systems, Aquafortus, Hyrec, Fluid Technology Solutions, De.mem, EDERNA, Fluvicon

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978